Wealthfront Advisers »

Alnylam Pharmaceuticals shares owned by Wealthfront Advisers

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Wealthfront Advisers from 13F filings

Historical chart of Wealthfront Advisers investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Wealthfront Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Wealthfront Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 8.1k 149.45
2023-12-31 $2.2M 12k 191.41
2023-09-30 $2.2M 12k 177.10
2023-06-30 $5.3M 28k 189.94
2023-03-31 $6.9M 34k 200.32
2022-12-31 $7.7M 33k 237.65
2022-09-30 $3.7M 18k 200.15
2022-06-30 $2.1M 14k 145.84
2022-03-31 $2.1M 13k 163.25
2021-12-31 $224k 1.3k 169.83